Elequin Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Elequin Capital’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137	Sell	7 -20	-74%	-$489	﹤0.01%	604
2025 Q4	$723	Buy	+27	New	+$695	﹤0.01%	382
2025 Q3	–	Sell	-14	Closed	-$321	–	155
2025 Q2	$321	Buy	+14	New	+$347	﹤0.01%	355
2024 Q4	–	Sell	-60	Closed	-$2.91K	–	522
2024 Q3	$2.91K	Buy	+60	New	+$2.63K	﹤0.01%	314
2024 Q2	–	Sell	-110	Closed	-$4.83K	–	199
2024 Q1	$4.83K	Buy	+110	New	+$5.68K	﹤0.01%	155

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Elequin Capital's AMPH Position: Q1 2026 in Review

Elequin Capital reduced its Amphastar Pharmaceuticals (AMPH) stake by 74% in Q1 2026, selling an estimated $489 and leaving 7 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Elequin Capital first reported a position in AMPH in Q1 2024 and has held it in 5 quarters since. The position peaked at $4.83K in Q1 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Elequin Capital held 7 shares of Amphastar Pharmaceuticals worth $137 as of Q1 2026.
Elequin Capital sold 20 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $489.
Amphastar Pharmaceuticals made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #604 holding.
Elequin Capital first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
Elequin Capital's Amphastar Pharmaceuticals position peaked at $4.83K in Q1 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.